Why Reproductive Endocrinologists Get Sued: Embryo and Specimen Errors, Genetic Misreads, and the Chain-of-Custody Record

By John Mahoney · June 2026 · 9 min read

Reproductive endocrinology and infertility (REI) is a specialty where the malpractice profile does not match the procedure risk. The clinical procedures — ovarian stimulation, egg retrieval, embryo transfer — are generally safe, and the field's overall claim frequency is low. But REI carries a category of exposure almost no other specialty shares: an error in the embryology lab can destroy, lose, or switch the genetic material a family has invested years and tens of thousands of dollars to create, and the harm is uniquely irreversible and emotionally devastating. For a med-mal attorney, the REI file is two cases in one — a conventional clinical-care case about stimulation, complications, and consent, and a specimen-handling case that lives in the embryology lab's chain-of-custody record.

This guide walks through why reproductive endocrinologists get sued — the dominant allegation types, the events that drive the high-exposure claims, why the lab chain-of-custody and consent records decide defensibility, and how to separate an inherent IVF failure from a negligent error — for plaintiff and defense attorneys triaging a fertility case.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The standard of care in reproductive endocrinology and embryology is jurisdiction- and fact-specific, and the law governing embryo and gamete claims is evolving and varies widely by state. Always verify the controlling standard and authority and the underlying clinical, lab, and consent record before relying on any generalization.

The Frequency and Severity Reality

By raw claim frequency, REI is a lower-risk specialty. The procedures are elective and planned, serious clinical complications are uncommon, and patients are generally healthy. But two features make the severity and notoriety of REI claims disproportionate to their number.

First, the harm in a specimen case is irreplaceable. A lost embryo cohort, a storage-tank failure, or a gamete mix-up cannot be undone, and the emotional damages are profound — these cases also tend to draw class actions and media attention when a single tank or lab failure affects many families. Second, the field generates novel legal theories — wrongful birth, breach of contract and bailment over stored specimens, emotional-distress claims, and disputes over the legal status of embryos — that vary sharply by jurisdiction and can expand or contract exposure independent of the clinical merits. The result is a low-frequency specialty with an outsized, and legally unsettled, severity tail. As always, treat any generalization as a starting point and confirm both the facts and the controlling law.

The Dominant Allegation Types

REI allegations split cleanly between laboratory/specimen failures and clinical-care failures:

• Lost, destroyed, or damaged embryos or gametes — storage-tank or cryopreservation failures, thawing errors, or mishandling that destroys the specimens.
• Embryo or gamete mix-up — the wrong embryo, egg, or sperm used, or specimens switched between patients, through a labeling or chain-of-custody failure.
• Genetic-testing error — misread, mis-reported, or mis-acted-upon preimplantation genetic testing or carrier screening, leading to transfer of an affected embryo or a wrongful-birth theory.
• Severe ovarian hyperstimulation syndrome (OHSS) — failure to anticipate, monitor, or manage a high-responder, the most serious clinical complication of stimulation.
• Missed ectopic pregnancy or procedural complication — failure to diagnose ectopic after transfer, or injury during retrieval (bleeding, infection, organ injury).
• Inadequate informed consent — over storage, disposition, genetic-testing limitations, multiple-gestation risk, and the realistic chance of success.

The allegation prior in REI is unusual: a process/chain-of-custody question layered over a conventional clinical-care question. The central inquiry is whether the harm reflects a deviation in specimen handling, monitoring, or genetic interpretation, or an inherent and disclosed limitation of fertility treatment.

The Events That Drive the Claims

REI claims concentrate around a short list of high-exposure events:

• A cryostorage or tank failure destroying a cohort of embryos or eggs — often a systems and monitoring failure, and frequently a multi-patient event.
• A gamete or embryo mix-up traceable to a labeling, witnessing, or chain-of-custody lapse — the highest-exposure single-patient case.
• Transfer of an affected embryo after a genetic-testing error — a misread or mis-reported result driving a wrongful-birth theory.
• Life-threatening OHSS in a high-responder who was not adequately monitored or whose protocol was not adjusted.
• A missed ectopic pregnancy after embryo transfer, with rupture and hemorrhage.
• A retrieval complication — bleeding, infection, or visceral injury — framed as negligent technique.

The specimen-handling events and the genetic-testing error are the high-exposure flags in this specialty — the harm is irreversible and the damages and legal theories are large. A disclosed, well-monitored cycle that simply failed, or a recognized complication that was anticipated and managed, is the defensible floor. A screen should weight these very differently.

Why the Chain-of-Custody and Consent Records Decide the Case

Two record sets carry most REI cases, and they map onto the two halves of the specialty.

The embryology lab record governs the specimen claims, and it is unusually granular and witnessed. It includes specimen labeling and identification, double-witnessing logs at each handling step, freeze and thaw records, storage-tank monitoring and alarm logs, and transfer documentation. A complete chain — correct identification confirmed and independently witnessed at every step, tanks monitored, alarms functioning — is the strongest defense to a mix-up or loss claim. Gaps — a missing witness signature, an ambiguous or duplicated label, an unmonitored or unalarmed tank, a thaw record that does not match the transfer — become the plaintiff's case. In a specimen claim, the lab record, not the physician's clinical note, is decisive.

The clinical and consent record governs the stimulation, complication, and disclosure claims — the OHSS monitoring trend, the ectopic surveillance, and the consent documents covering storage, disposition, genetic-testing limitations, multiple-gestation risk, and realistic success rates. Because so much REI exposure is about expectation, disclosure, and the legal status and disposition of specimens, a specific, signed, contemporaneous consent set is one of the most important documents in the file. Reading the lab chain-of-custody and the consent record together is what separates a payable error from an inherent, disclosed limitation of fertility care.

Strong Case vs. Weak Case in Reproductive Endocrinology

Both sides screen the same records for the same signals, and the factors separating a strong case from a weak one are largely symmetrical.

What strengthens a plaintiff's case

• A chain-of-custody or witnessing gap in the embryology lab record that coincides with a documented loss, switch, or mix-up of specimens.
• A storage-tank failure with absent or non-functioning monitoring and alarm logs.
• A genetic-testing report misread or mis-reported, with transfer of an affected embryo that the report should have flagged.
• An OHSS or ectopic case with a monitoring trend in the record showing a missed or delayed response, or a consent set silent on a realized risk or on specimen disposition.

What strengthens the defense

• A complete, double-witnessed chain-of-custody record showing correct identification at every handling step, with functioning tank monitoring.
• A documented, protocol-concordant response to a high-responder, with appropriate OHSS monitoring and adjustment.
• A genetic report accurately transmitted and acted on within the disclosed limits of the test.
• A specific, signed consent set covering storage, disposition, genetic-testing limitations, multiple-gestation risk, and realistic success — and an outcome that was an inherent, disclosed limitation of treatment.

REI cases also turn heavily on the controlling law — whether the jurisdiction recognizes the claimed theory (wrongful birth, bailment, emotional distress over embryos) materially shapes exposure independent of the clinical facts. Screen the legal theory and the chain-of-custody record together.

The Expert and Merit Questions Come Early

Because REI claims turn on a specialized clinical and laboratory standard of care, the expert is central and the qualification fight starts at the pre-suit gate. Most cases need a board-certified reproductive endocrinologist, with an embryologist or laboratory director added on specimen handling and chain-of-custody and a geneticist where preimplantation or carrier testing is at issue. The expert who signs the certificate of merit must typically be qualified to opine against the defendant, and the same specialty-match and reliability questions feed directly into a later motion to exclude. Screening for both at intake prevents the avoidable losses — the strong specimen-handling case dismissed on a defective merit filing, or the expert who clears the merit gate but cannot survive a reliability challenge.

Bottom Line

Reproductive endocrinology is a low-frequency specialty with an outsized, legally unsettled severity tail. The clinical procedures are generally safe, but the embryology lab carries a category of irreversible, high-exposure risk — lost, destroyed, or mismatched embryos and gametes — that no conventional clinical specialty shares. The dominant allegations split between specimen and chain-of-custody failures, genetic-testing errors, OHSS, missed ectopic, and consent disputes. The embryology lab's witnessed chain-of-custody record and the clinical consent set are the case: complete, they are a powerful defense; gapped, they are the plaintiff's strongest exhibits.

For both sides, the work is the same: read the lab chain-of-custody as carefully as the clinical chart, confirm witnessing and tank monitoring against any alleged loss or switch, check the genetic report against what was transferred, separate an inherent IVF failure from a negligent error, screen the controlling legal theory, and confirm the expert match and merit filing early. The merits should decide the case — so verify every generalization against the actual record.

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →